Literature DB >> 8969169

The human type I interferon receptor. Identification of the interferon beta-specific receptor-associated phosphoprotein.

E Croze1, D Russell-Harde, T C Wagner, H Pu, L M Pfeffer, H D Perez.   

Abstract

We used specific antibodies recognizing the receptor 1 (IFNAR1) and the recently cloned receptor 2.2 (IFNAR2.2) chains of the human type I interferon receptor complex to demonstrate that the interferon beta (IFN-beta)-specific receptor-associated phosphoprotein is IFNAR2.2 and not an unknown or additional receptor component. Immunoprecipitation experiments demonstrated that IFNAR2.2 is present in Daudi cells as a cell surface protein of approximately 90-100 kDa, which is tyrosine-phosphorylated and associated with IFNAR1, upon stimulation of cells with IFN-beta. IFNAR2.2 was not detected associated with IFNAR1 in cells stimulated with IFN-alpha, suggesting differences in receptor interaction between the two type I interferons. Both IFNAR1 and IFNAR2.2 undergo tyrosine phosphorylation upon induction by either IFN-alpha or IFN-beta. Therefore, it is unclear as to why IFNAR2.2 is not detectable in IFNAR1 immunoprecipitates in IFN-beta-treated cells. These data suggest that, although IFN-alpha and IFN-beta may utilize similar receptor chains, they interact with IFNAR1 and IFNAR2.2 in different ways.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8969169     DOI: 10.1074/jbc.271.52.33165

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Impaired antiviral response and alpha/beta interferon induction in mice lacking beta interferon.

Authors:  R Deonarain; A Alcamí; M Alexiou; M J Dallman; D R Gewert; A C Porter
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  The crystal structure of human interferon beta at 2.2-A resolution.

Authors:  M Karpusas; M Nolte; C B Benton; W Meier; W N Lipscomb; S Goelz
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  IFN-β-specific signaling via a unique IFNAR1 interaction.

Authors:  Surinder Kaur; Leonidas C Platanias
Journal:  Nat Immunol       Date:  2013-09       Impact factor: 25.606

4.  STAT3 complements defects in an interferon-resistant cell line: evidence for an essential role for STAT3 in interferon signaling and biological activities.

Authors:  C H Yang; A Murti; L M Pfeffer
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

5.  Ligand-independent interaction of the type I interferon receptor complex is necessary to observe its biological activity.

Authors:  Christopher D Krause; Gina Digioia; Lara S Izotova; Junxia Xie; Youngsun Kim; Barbara J Schwartz; Olga V Mirochnitchenko; Sidney Pestka
Journal:  Cytokine       Date:  2013-07-03       Impact factor: 3.861

6.  Determination of the human type I interferon receptor binding site on human interferon-alpha2 by cross saturation and an NMR-based model of the complex.

Authors:  Sabine R Quadt-Akabayov; Jordan H Chill; Rina Levy; Naama Kessler; Jacob Anglister
Journal:  Protein Sci       Date:  2006-09-25       Impact factor: 6.725

7.  Inquiring into the differential action of interferons (IFNs): an IFN-alpha2 mutant with enhanced affinity to IFNAR1 is functionally similar to IFN-beta.

Authors:  Diego A Jaitin; Laila C Roisman; Eva Jaks; Martynas Gavutis; Jacob Piehler; Jose Van der Heyden; Gilles Uze; Gideon Schreiber
Journal:  Mol Cell Biol       Date:  2006-03       Impact factor: 4.272

8.  Comparable potency of IFNalpha2 and IFNbeta on immediate JAK/STAT activation but differential down-regulation of IFNAR2.

Authors:  Zrinka Marijanovic; Josiane Ragimbeau; José van der Heyden; Gilles Uzé; Sandra Pellegrini
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

Review 9.  Multifarious determinants of cytokine receptor signaling specificity.

Authors:  Ignacio Moraga; Jamie Spangler; Juan L Mendoza; K Christopher Garcia
Journal:  Adv Immunol       Date:  2014       Impact factor: 3.543

Review 10.  Opposing Roles of Type I Interferons in Cancer Immunity.

Authors:  Giselle M Boukhaled; Shane Harding; David G Brooks
Journal:  Annu Rev Pathol       Date:  2020-12-02       Impact factor: 23.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.